CD4 and cancer: The results indicated that ANXA4 expression was significantly associated with B cell in 15 cancer types, macrophage in 17 cancer types, dendritic cell in 20 cancer types, neutrophil in 16 cancer types, CD4+ T cell in 14 cancer types, and CD8+ T cell in 16 cancer types.